CDPATH™
Vedolizumab-4015
Approved other active
Quick answer
CDPATH™ for Crohn's Disease is a Approved program (other) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Crohn's Disease
- Phase
- Approved
- Modality
- other
- Status
- active